A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2004
12/28/2004	US6835751 Bicyclic amino acids as pharmaceutical agents
12/28/2004	US6835744 3,3-substituted indoline derivatives
12/28/2004	US6835740 Methods for treating sleep apnea and sleep induced apnea using optically pure (+) norcisapride
12/28/2004	US6835738 Phenylalanine enamide derivatives
12/28/2004	US6835737 Quinoline inhibitors of cGMP phosphodiesterase
12/28/2004	US6835735 Anticancer, tyrosine kinase inhibitors
12/28/2004	US6835731 Chemokine receptor binding heterocyclic compounds
12/28/2004	US6835730 4-heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof
12/28/2004	US6835728 Drug combination for the treatment of depression and related disorders comprising mirtazapine
12/28/2004	US6835727 Bone disorders; osteoporosis; rheumatic diseases
12/28/2004	US6835714 Heterocyclic compounds, intermediates thereof and elastase inhibitors
12/28/2004	US6835711 Use of poly-Glu,Tyr for neuroprotective therapy
12/28/2004	US6835564 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same
12/28/2004	US6835401 Method of treating diseases caused by over-production of free-radicals
12/28/2004	CA2226039C Pyridylfuran and pyridylthiophene compounds
12/28/2004	CA2161443C Large potassium bicarbonate crystals and process for the preparation thereof
12/28/2004	CA2128103C Formulation and use of carotenoids in treatment of cancer
12/28/2004	CA2126072C Tri-substituted phenyl derivatives and processes for their preparation
12/23/2004	WO2004111234A1 Novel protein
12/23/2004	WO2004111052A1 Pyrrolopyrimidine derivatives as modulators of multi-drug resistance (mdr)
12/23/2004	WO2004111037A1 Cyclic tertiary amine compound
12/23/2004	WO2004111028A1 Cyclic onium compounds and glucosidase inhibitors
12/23/2004	WO2004111012A1 Imidazolidine derivative
12/23/2004	WO2004110980A1 Sphingolipids' polyalkylamines conjugates
12/23/2004	WO2004110499A1 Sphingolipids polyalkylamine conjugates for use in transfection
12/23/2004	WO2004110496A1 Sphingoid polyalkylamine conjugates for vaccination
12/23/2004	WO2004110489A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE
12/23/2004	WO2004110471A1 Preventive or remedy for disease associated with apoptosis
12/23/2004	WO2004110457A1 Matrix metalloproteinases inhibitors for the stimulation and protection of bone marrow stem cells
12/23/2004	WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
12/23/2004	WO2004110448A1 Medicinal composition containing benidipine hydrochloride
12/23/2004	WO2004110419A1 Agonist agents and medicinal compositions
12/23/2004	WO2004045563A3 Method of treatment of myocardial infarction
12/23/2004	WO2003101995A8 Camptothecins with a modified lactone ring
12/23/2004	WO2003089002A9 Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia
12/23/2004	WO2003076569A3 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
12/23/2004	US20040260268 Drug/drug delivery systems for the prevention and treatment of vascular disease
12/23/2004	US20040260096 Novel substituted 4-phenyl-4-{1h-imidazol-2-yl}-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/23/2004	US20040260095 human immunodeficiency virus (HIV) protease inhibitors; AIDS; prophylaxis
12/23/2004	US20040260094 such as 8-amino-4-benzylamino-quinoline-3-carboxylic acid ethyl ester; for treatment of Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS, stroke, ischemia, traumatic brain injury, spinal cord injury or osteoarthritis
12/23/2004	US20040260088 Novel compounds
12/23/2004	US20040260069 Modified anti-tnf aplha antibody
12/23/2004	US20040259939 Dissolving and precipitation a solution of citalopram in acid with solvent, adding base to liberate free base.
12/23/2004	US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof
12/23/2004	US20040259928 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/23/2004	US20040259921 EP4 receptor selective agonists in the treatment of osteoporosis
12/23/2004	US20040259920 Acne treatment
12/23/2004	US20040259911 Quinoline derivatives process of synthesis and medicaments containing these derivatives
12/23/2004	US20040259908 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid
12/23/2004	US20040259907 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents
12/23/2004	US20040259894 inhibitors of cyclin-dependent kinases (CDKs); cancer, leukemia, psoriasis
12/23/2004	US20040259893 Use of tyrosine kinase inhibitions for treating allergic diseases
12/23/2004	US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example
12/23/2004	US20040259888 Antiischemic agents; cardiovascular disorders; analgesics; neurodegenerative disease
12/23/2004	US20040259886 Compositions and methods for treating osteoporosis and lowering cholesterol
12/23/2004	US20040259883 Thiazolidine derivative and medicinal use thereof
12/23/2004	US20040259876 Bicyclic compound, production and use thereof
12/23/2004	US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents
12/23/2004	US20040259865 Laxative; adenosine receptor antagonist
12/23/2004	US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof
12/23/2004	US20040259858 such as 3-(2-methyl-4-pyrrolidin-1-yl-quinolin-7-yl-methoxy)-benzonitrile; neuropeptide y receptor antagonists; for treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity
12/23/2004	US20040259842 Anticoagulants ; antiischemic agents; autoimmune disease; antihistamines; antiallergens; antihistamines; brain disorders; kidney disease; pancreatitis; Alzheimer's disease
12/23/2004	US20040259840 Using phosphoglycerides, lipid having sphingosine base, glycerides and sterol; wound healing agents; atherosclerosis
12/23/2004	US20040259833 DNA methyl transferase inhibitors
12/23/2004	US20040259826 Mitotic kinesin inhibitors
12/23/2004	US20040259822 Antibody which recognizes epitope containing nucleic acid coupled to active protein; hybridomas
12/23/2004	US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents
12/23/2004	US20040259820 Kit for delivering decitabine in vivo
12/23/2004	US20040259810 Porphyrin derivatives for photodynamic therapy
12/23/2004	US20040259795 Reducing sepsis; binding polypeptide to monoclonal antibody ; intensify gene expression; wound healing agents
12/23/2004	US20040259787 C1q and collectin receptor
12/23/2004	US20040259767 Antiproliferative agents; therapy for human progessive leukoencephalophy ; suppression of dna viruses; anticancer agents
12/23/2004	US20040259766 Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis
12/23/2004	US20040259248 RNA interference mediating small RNA molecules
12/23/2004	US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference)
12/23/2004	US20040259201 Recombinant surfactant protein D compositions and methods of use thereof
12/23/2004	US20040259171 P2Y4 antibody and methods of use
12/23/2004	US20040259156 Bispecific immunoglobulin-like antigen binding proteins and method of production
12/23/2004	US20040259154 Preparation of metallic nanoparticle with shell-crosslinked micelle as mold
12/23/2004	US20040259150 Method of enhancing of binding activity of antibody composition to Fcgamma receptor IIIa
12/23/2004	US20040259110 Gene PRV-1 and its use
12/23/2004	US20040258826 Matrix-forming composition containing pectin
12/23/2004	US20040258771 Reduced toxicity cisplatin formulations and methods for using the same
12/23/2004	US20040258739 Plaster for the treatment of dysfunctions and disorders of nails
12/23/2004	US20040258704 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation
12/23/2004	US20040258692 Method for the treatment of cardiotoxicity induced by antitumor compounds
12/23/2004	US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies
12/23/2004	US20040258656 Identified via SELEX method; phosphate-containing ligand is conjugated to polyoxyethylene glycol; transforming growth factor (TGF); pharmacokinetics
12/23/2004	US20040258622 Nonozone depleting aerosol formulation employing hydrofluoroalkane propellants
12/23/2004	US20040255956 Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs
12/23/2004	CA2528929A1 Cyclic tertiary amine compound
12/23/2004	CA2528883A1 Pharmaceutical compositions for preventing or treating th1-mediated immune diseases
12/23/2004	CA2528402A1 Sphingoid polyalkylamine conjugates for vaccination
12/22/2004	EP1489187A1 Osteoclast differentiation inhibitors
12/22/2004	EP1489186A1 Angiogenesis inhibitors
12/22/2004	EP1489183A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
12/22/2004	EP1489179A1 Antiopoietin-related growth factor
12/22/2004	EP1489177A1 Cdc7-ask kinase complex, substrate of the kinase complex, antibody specific to the substrate, and method of screening compound capable of inhibiting cdc7-ask kinase using the same
12/22/2004	EP1489170A1 Transporter selectively transporting sulfate conjugate and its gene
12/22/2004	EP1489168A1 Protein sustaining undifferentiated stem cells as such

1 ... 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 ... 1564